Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

1.1K
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.1K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

411
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
411
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

1.5K
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Systemic sclerosis. Part II: perioperative considerations.

BJA education·2023
Same author

Systemic sclerosis. Part I: epidemiology, diagnosis and therapy.

BJA education·2023
Same author

A randomised trial of bilateral erector spinae plane block vs. no block for thoracolumbar decompressive spinal surgery.

Anaesthesia·2021
Same author

Are we underestimating the risk of major adverse cardiac events and myocardial injury after cancer surgery?

Anaesthesia·2021
Same author

Anaesthesia for breast surgery.

BJA education·2021
Same author

Anaesthesia, analgesia, and the surgical stress response.

BJA education·2021

Related Experiment Video

Updated: Mar 23, 2026

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
07:50

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model

Published on: September 3, 2020

5.0K

Understanding STAT3 signaling in cardiac ischemia.

K E O'Sullivan1, E P Breen2, H C Gallagher3,4,5

  • 1The Mater Private Hospital, Eccles St, Dublin 7, Ireland. kaosulli@tcd.ie.

Basic Research in Cardiology
|March 28, 2016
PubMed
Summary

Cardiovascular disease, a leading cause of death, can be treated by targeting the STAT3 pathway. Activating STAT3 offers cardioprotective effects against ischemia, presenting a promising therapeutic strategy for heart attack patients.

Keywords:
CardiomyocyteFibroblastHIF-1αMyocardial ischemiaSTAT3

More Related Videos

Murine Isolated Heart Model of Myocardial Stunning Associated with Cardioplegic Arrest
08:30

Murine Isolated Heart Model of Myocardial Stunning Associated with Cardioplegic Arrest

Published on: August 6, 2015

12.2K
Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury
07:23

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury

Published on: March 7, 2022

7.5K

Related Experiment Videos

Last Updated: Mar 23, 2026

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
07:50

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model

Published on: September 3, 2020

5.0K
Murine Isolated Heart Model of Myocardial Stunning Associated with Cardioplegic Arrest
08:30

Murine Isolated Heart Model of Myocardial Stunning Associated with Cardioplegic Arrest

Published on: August 6, 2015

12.2K
Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury
07:23

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury

Published on: March 7, 2022

7.5K

Area of Science:

  • Cardiology
  • Molecular Biology
  • Biomedical Research

Background:

  • Cardiovascular disease is the primary global cause of mortality, with acute myocardial infarction causing millions of deaths annually.
  • Current treatments for myocardial infarction focus on restoring blood flow, but reperfusion still results in significant infarct size.
  • Signaling transducer and activator of transcription 3 (STAT3) is recognized for its cardioprotective properties.

Purpose of the Study:

  • To review existing evidence on manipulating the STAT3 pathway for therapeutic benefit in cardiac ischemia.
  • To explore the role of STAT3 in cardiomyocyte function and the cardiac microenvironment.
  • To identify future research directions for STAT3-based cardiac therapies.

Main Methods:

  • Review of in vitro and in vivo studies investigating STAT3 activation in cardiac ischemia.
  • Analysis of STAT3's canonical and non-canonical signaling pathways.
  • Examination of STAT3's influence on mitochondrial and transcriptional responses.

Main Results:

  • Evidence supports STAT3 activation as a mechanism for cardioprotection against ischemia.
  • STAT3 modulates mitochondrial function and transcriptional responses, contributing to a protective effect.
  • STAT3 influences cardiomyocyte function and interacts with cardiac fibroblasts.

Conclusions:

  • Targeting the STAT3 signaling pathway holds therapeutic potential for mitigating cardiac ischemia damage.
  • Further research is warranted to fully elucidate and exploit STAT3's role in cardiac protection.
  • Modulating STAT3 offers a promising avenue for developing novel treatments for cardiovascular diseases.